Cromolyn Sodium Reduces LPS-induced Pulmonary Fibrosis by Inhibiting the EMT Process Enhanced by MC-derived IL-13

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2025 Jan 6

PMID 39762844

Authors

Cheng Tan

Hang Zhou

Qiangfei Xiong

Xian Xian

Qiyuan Liu

Zexin Zhang

Jingjing Xu

Hao Yao

Affiliations

Soon will be listed here.

Abstract

Background: Sepsis is a systemic inflammatory response caused by infection. When this inflammatory response spreads to the lungs, it can lead to acute lung injury (ALI) or more severe acute respiratory distress syndrome (ARDS). Pulmonary fibrosis is a potential complication of these conditions, and the early occurrence of pulmonary fibrosis is associated with a higher mortality rate. The underlying mechanism of ARDS-related pulmonary fibrosis remains unclear.

Methods: To evaluate the role of mast cell in sepsis-induced pulmonary fibrosis and elucidate its molecular mechanism. We investigated the level of mast cell and epithelial-mesenchymal transition(EMT) in LPS-induced mouse model and cellular model. We also explored the influence of cromolyn sodium and mast cell knockout on pulmonary fibrosis. Additionally, we explored the effect of MC-derived IL-13 on the EMT and illustrated the relationship between mast cell and pulmonary fibrosis.

Results: Mast cell was up-regulated in the lung tissues of the pulmonary fibrotic mouse model compared to control groups. Cromolyn sodium and mast cell knockout decreased the expression of EMT-related protein and IL-13, alleviated the symptoms of pulmonary fibrosis in vivo and in vitro. The PI3K/AKT/mTOR signaling was activated in fibrotic lung tissue, whereas Cromolyn sodium and mast cell knockout inhibited this pathway.

Conclusion: The expression level of mast cell is increased in fibrotic lungs. Cromolyn sodium intervention and mast cell knockout alleviate the symptoms of pulmonary fibrosis probably via the PI3K/AKT/mTOR signaling pathway. Therefore, mast cell inhibition is a potential therapeutic target for sepsis-induced pulmonary fibrosis.

References

Yue J, Tan Y, Huan R, Guo J, Yang S, Deng M . Mast cell activation mediates blood-brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway. Front Immunol. 2023; 14:1090288. PMC: 9929573. DOI: 10.3389/fimmu.2023.1090288. View

Andersson C, Andersson-Sjoland A, Mori M, Hallgren O, Pardo A, Eriksson L . Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis. Respir Res. 2011; 12:139. PMC: 3209449. DOI: 10.1186/1465-9921-12-139. View

Henderson N, Rieder F, Wynn T . Fibrosis: from mechanisms to medicines. Nature. 2020; 587(7835):555-566. PMC: 8034822. DOI: 10.1038/s41586-020-2938-9. View

Meduri G, Eltorky M . Understanding ARDS-associated fibroproliferation. Intensive Care Med. 2015; 41(3):517-20. DOI: 10.1007/s00134-014-3613-0. View

Inoue Y, King Jr T, Tinkle S, Dockstader K, Newman L . Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am J Pathol. 1996; 149(6):2037-54. PMC: 1865345. View

Cong L, Li T, Wang H, Wu Y, Wang S, Zhao Y . IL-17A-producing T cells exacerbate fine particulate matter-induced lung inflammation and fibrosis by inhibiting PI3K/Akt/mTOR-mediated autophagy. J Cell Mol Med. 2020; 24(15):8532-8544. PMC: 7412687. DOI: 10.1111/jcmm.15475. View

Hu X, Xu Q, Wan H, Hu Y, Xing S, Yang H . PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab Invest. 2020; 100(6):801-811. DOI: 10.1038/s41374-020-0404-9. View

Virk H, Arthur G, Bradding P . Mast cells and their activation in lung disease. Transl Res. 2016; 174:60-76. DOI: 10.1016/j.trsl.2016.01.005. View

Meyer N, Gattinoni L, Calfee C . Acute respiratory distress syndrome. Lancet. 2021; 398(10300):622-637. PMC: 8248927. DOI: 10.1016/S0140-6736(21)00439-6. View

10.

Soromou L, Chen N, Jiang L, Huo M, Wei M, Chu X . Astragalin attenuates lipopolysaccharide-induced inflammatory responses by down-regulating NF-κB signaling pathway. Biochem Biophys Res Commun. 2012; 419(2):256-61. DOI: 10.1016/j.bbrc.2012.02.005. View

11.

Mikacenic C, Moore R, Dmyterko V, West T, Altemeier W, Liles W . Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia. Crit Care. 2018; 22(1):358. PMC: 6307268. DOI: 10.1186/s13054-018-2290-8. View

12.

Reber L, Daubeuf F, Pejler G, Abrink M, Frossard N . Mast cells contribute to bleomycin-induced lung inflammation and injury in mice through a chymase/mast cell protease 4-dependent mechanism. J Immunol. 2014; 192(4):1847-54. DOI: 10.4049/jimmunol.1300875. View

13.

Berthiaume Y, Matthay M . Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurobiol. 2007; 159(3):350-9. PMC: 2682357. DOI: 10.1016/j.resp.2007.05.010. View

14.

Masuda T, Tanaka H, Komai M, Nagao K, Ishizaki M, Kajiwara D . Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma. Clin Exp Allergy. 2003; 33(5):705-13. DOI: 10.1046/j.1365-2222.2003.01588.x. View

15.

Dudeck A, Dudeck J, Scholten J, Petzold A, Surianarayanan S, Kohler A . Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity. 2011; 34(6):973-84. DOI: 10.1016/j.immuni.2011.03.028. View

16.

Yu M, Qi B, Xiaoxiang W, Xu J, Liu X . Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. Biomed Pharmacother. 2017; 90:677-685. DOI: 10.1016/j.biopha.2017.04.001. View

17.

Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S . Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev. 2019; 28(151). PMC: 9489101. DOI: 10.1183/16000617.0100-2018. View

18.

Melo-Cardenas J, Bezavada L, Crawford J, Gurbuxani S, Cotton A, Guolian Kang . IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms. Blood. 2022; 140(26):2805-2817. DOI: 10.1182/blood.2022017326. View

19.

Chi M, Liu J, Mei C, Shi Y, Liu N, Jiang X . TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. J Exp Clin Cancer Res. 2022; 41(1):175. PMC: 9112458. DOI: 10.1186/s13046-022-02377-3. View

20.

Pei X, Zheng F, Li Y, Lin Z, Han X, Feng Y . Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway. Cells. 2022; 11(3). PMC: 8834116. DOI: 10.3390/cells11030346. View